Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FLUVOXAMINE MALEATE USP, with a corresponding US DMF Number 16174.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 24, 2021, and payment made on September 21, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II